KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Encompass Health (EHC) Other Non Operating Income (2016 - 2026)

Encompass Health (EHC) has disclosed Other Non Operating Income for 18 consecutive years, with $18.7 million as the latest value for Q1 2026.

  • For Q1 2026, Other Non Operating Income changed N/A year-over-year to $18.7 million; the TTM value through Mar 2026 reached $29.1 million, up 977.78%, while the annual FY2025 figure was $18.8 million, 3233.33% up from the prior year.
  • Other Non Operating Income hit $18.7 million in Q1 2026 for Encompass Health, up from $3.7 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $18.7 million in Q1 2026 and bottomed at -$6.8 million in Q4 2023.
  • Average Other Non Operating Income over 5 years is $2.4 million, with a median of $2.7 million recorded in 2023.
  • Year-over-year, Other Non Operating Income tumbled 121.43% in 2022 and then soared 1950.0% in 2025.
  • Encompass Health's Other Non Operating Income stood at -$3.8 million in 2022, then tumbled by 78.95% to -$6.8 million in 2023, then skyrocketed by 97.06% to -$200000.0 in 2024, then skyrocketed by 1950.0% to $3.7 million in 2025, then soared by 405.41% to $18.7 million in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at $18.7 million, $3.7 million, and $6.7 million for Q1 2026, Q4 2025, and Q2 2025 respectively.